SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Merck
Merck
Page 8 of 9
Finance
Here’s How Drug Prices Actually Work
By
Lauren Silva Laughlin
April 26, 2016
Health
The Two Mercks Are Locking Horns in a Naming Trademark Spat
By
Sy Mukherjee
April 18, 2016
Health
Watchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law
By
Reuters
March 31, 2016
Health
Gilead Ordered to Pay Merck $200 Million in Hepatitis C Dispute
By
Reuters
March 25, 2016
Health
Gilead May Have to Pay Rival Merck Billions in Royalties
By
Sy Mukherjee
March 23, 2016
Health
Merck Just Made a $20 Million Bet On Experimental Harvard Cancer Tech
By
Sy Mukherjee
March 22, 2016
Health
Why This Bristol-Myers Cancer Drug Is Crushing Its Rivals
By
Sy Mukherjee
March 14, 2016
Health
Sanofi and Merck Are Ditching a 22-Year-Old Joint Venture
By
Sy Mukherjee
March 8, 2016
Health
Scientists Just Made a Major Breakthrough in Personalized Cancer Treatment
By
Sy Mukherjee
March 4, 2016
Finance
Merck’s Blockbuster Drugs Are Losing Steam
By
Reuters
February 3, 2016
Finance
China Goes Shopping and General Motors Reports—5 Things to Know Today
By
Laura Lorenzetti
and
Ian Mount
February 3, 2016
Features
Gunboat diplomacy and Apple earnings — 5 things to know today
By
Tom Huddleston Jr.
October 27, 2015
Features
Apple’s earnings, baseball, and a Fed meeting — 5 things to know this week
By
Tom Huddleston Jr.
October 25, 2015
Finance
Eli Lilly adds one more to roster of failed heart drugs, and it won’t be the last
By
Laura Lorenzetti
October 12, 2015
International
New Ebola vaccine found to be 100% effective in recent trial
By
Reuters
July 31, 2015
Most Popular
Economy
Markets sold off after Powell said six words investors don’t want to hear: ‘Equity prices are fairly highly valued’
By
Jim Edwards
Success
Gen Z is reviving this boring job that millennials and boomers abandoned—and it's helping them land six-figure careers...
By
Preston Fore
North America
'The frustration is overwhelming': Soybean farmers feel betrayed as Argentina blows a hole in rural America’s $47...
By
Sasha Rogelberg